|Bid||37.23 x 800|
|Ask||38.40 x 2900|
|Day's Range||37.17 - 37.82|
|52 Week Range||30.67 - 62.75|
|Beta (3Y Monthly)||0.88|
|PE Ratio (TTM)||1.71|
|Forward Dividend & Yield||2.72 (7.48%)|
|1y Target Est||44.12|
Contrary to conventional wisdom, you don't need a hefty trust fund or deep pockets like mutual funds and other institutional players to start investing.
British American Tobacco, which had its own Formula One team before selling to Honda in 2006, is returning to the sport under a multi-year global partnership with McLaren. Both sides said in a statement announcing the deal on Monday that the partnership will focus solely on BAT’s "potentially reduced risk products" with an emphasis on technology and innovation. "McLaren Applied Technologies will work with BAT on areas including battery technology and advanced materials.
Key Takeaways from Philip Morris’s Fourth-Quarter EarningsFourth-quarter earningsPhilip Morris International (PM) posted its fourth-quarter earnings on February 7. For the quarter ended on December 31, the company posted adjusted EPS of $1.25 on
The tobacco giant is pulling a “reverse Yankee” by marketing an upcoming bond issue primarily in Europe, because U.S. investors have quality alternatives to corporate debt now that the Fed has raised interest rates nine times this cycle.
Will Philip Morris’s Q4 Earnings Boost Its Stock Price?Stock performancePhilip Morris International (PM) is scheduled to post its fourth-quarter earnings results before the market opens on February 7. As of February 1, the stock was trading at
Philip Morris' (PM) performance in Q4 to be weighed down by declining cigarette sales volumes. However, strength in RRPs and pricing to offer some respite.
Altria Stock Rose ~3% after Q4 Earnings Met ExpectationsFourth-quarter performanceAltria Group (MO) posted its fourth-quarter earnings before the market opened on January 31. For the quarter ended on December 31, the company posted adjusted EPS of
Only two months since peaking at around $52 a share, Pyxus International (NYSE:PYX) is on the move again. On Jan 30, the stock rose 26% on no news. Perhaps speculators who missed out on the enormous rally in marijuana stocks are now looking at PYX stock. Or maybe the rebound in tobacco firms validates betting on Pyxus. So the question is, should you buy this stock today? Pyxus rose to the $52 level when, in October 2018, Citron wrote that Pyxus "has most to gain with a defined plan and management never seen before in Cannabis." In the month that followed, the stock lost all of those gains due to fundamentals. The firm posted third-quarter results that showed a serious deceleration in its business. Sales fell 12% from last year to $395 million. It struggled because of lower volumes and lower gross margins. With such weak figures, why should investors even consider this company? InvestorPlace - Stock Market News, Stock Advice & Trading Tips ### Second-Quarter Typically Weak for PYX Stock Pyxus reported weak Q2 numbers because it was a seasonally lower period for its business. Volumes fell in the period due to shipment timing, tougher year-over-year comparisons and the stronger U.S. dollar. The firm also faced foreign tariffs and increased tariffs on U.S. tobacco. This resulted in a net negative impact to operating income totaling $25 million for the full year. * 7 Stocks With Too Much Riding On China For Q2, the company lost $55.4 million, while adjusted EBITDA came in at $45.3 million. A delay in marijuana legalization in Canada delayed sales into the Q3 period. Since the company is scheduled to report results on Feb. 7 before market open, one might guess the markets are betting that Pyxus will realize cannabis sales and improved hemp sales. However, chances are good that the third quarter will benefit from a reversal from the seasonal Q2 weakness. Typically, product shipment picks up in the third and fourth quarter. So long as Pyxus had a good season in South America, it may realize higher revenue from the increased output. An increase in its building square footage is another positive catalyst for Pyxus. It had a delay in opening its facility, which also delayed shipments. With this issue resolved, it should achieve a stronger performance in many key geographies. These include Zimbabwe, Malawi, Uganda, Europe, Canada, the U.S. and Argentina. ### High Ambitions Pyxus is very ambitious with its supply output targets. An astute investor will notice that the firm has a market cap of around $130 million. And its balance sheet is not pretty: its debt to equity is 7.15 times, while its long-term debt/equity sits at 4.25 times. As mentioned many times already, the firm is growing its capacity, growing its volume, and is expanding into more provinces to increase its facility space. Pyxus has one notable facility in Prince Edward Island. On its conference call, it said it aimed to have another 300,000 square feet by the end of Dec. 2018. On its next call following its Q2 report, the firm should give an update on its status. And the growth in facilities does not stop there. Goldleaf has 200,000 square foot and could add another 700,000 square feet for this coming summer. The markets may have eased up on selling tobacco stocks like Phillip Morris International (NYSE:PM), Altria Group, Inc. (NYSE:MO) or British American Tobacco (NYSE:BTI). Fundamentally, though, tobacco is a negative headwind for Pyxus. Tobacco costs are going up and face tariffs. And even though tobacco-related SG&A fell year-over-year in Q2, gross profits are still falling. ### Your Takeaway for Pyxus Stock Pyxus is certainly compelling for speculators because it has the potential to grow its revenue levels. If management fills those warehouse spaces with goods, it just might deliver on an acceleration in revenue. Short-sellers started backing off, lowering their short interest from 2.94 million shares on Dec. 30, 2018, to 2.53 million by Jan. 14. If the company reports better results in its earnings report, the 26% rally in PYX stock may hold up. As of this writing, Chris Lau did not hold a position in any of the aforementioned securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Machine-Learning Stocks to Buy for a Smarter Portfolio * 10 Stocks to Sell in February * 10 Triple-A Stocks to Buy in February Compare Brokers The post What to Do After Pyxus International Stock Rallied by Over 25% appeared first on InvestorPlace.
The FTSE 100 index added 1.3 percent and the FTSE 250 rose 0.9 percent on their best day in ten days. Prime Minister Theresa May called on Britain's lawmakers to send a message to the European Union that they would support her plans to renegotiate the Brexit divorce deal. Retail stocks, led by a 5.7 percent jump in British American Tobacco after a rating upgrade, climbed to levels not seen since late November and were the biggest support to the main index.
What to Expect from Altria’s Fourth-Quarter EarningsStock performanceAltria Group (MO) is scheduled to post its fourth-quarter earnings before the market opens on January 31. As of January 25, Altria was trading at $44.24, which represents a fall
British American Tobacco PLC, Kellogg Co., Conagra Brands Inc. and Seneca Foods Corp have declined to their respective three-year lows
Altria (MO) gains from higher pricing as well as rising popularity of low risk tobacco products. However, declining cigarette sales volumes is a worry.
Does Altria’s Valuation Look Attractive after Recent Correction?Stock performanceOn January 22, Morgan Stanley downgraded Altria Group (MO) from “equal weight” to “underweight.” The downgrade led Altria’s stock price to fall to a
Altria Stock Fell More than 6% after Morgan Stanley’s DowngradeMorgan Stanley’s downgrade On January 22, Morgan Stanley downgraded Altria (MO) from “equal weight” to “underweight.” Morgan Stanley lowered the target price from $54 to $45.
British American Tobacco (BTI) has seen its stock fall by more than 50% in the last 52 weeks, all while its financial performance has never been better. More importantly, the underlying business will survive any short-term market volatility. Warning! GuruFocus has detected 1 Warning Sign with WFC.
Negative headlines and poor market conditions sometimes conspire to create incredible bargains for true contrarians. International tobacco stocks like Altria Group , Philip Morris International and British American Tobacco fall into that category right now.
The Surgeon General officially declared e-cigarette use as an epidemic among the youth. Yahoo Finance's Adam Shapiro, Julie Hyman and Ethan Wolf Mann discuss with Truth Initiative CEO, Robin Koval about the company launching a new first of its kind digital program to help address vaping for young adults.